Ind-Swift Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE915B01019
  • NSEID: INDSWFTLAB
  • BSEID: 532305
INR
316.95
-13.25 (-4.01%)
BSENSE

Nov 20

BSE+NSE Vol: 5.4 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 393806,
    "name": "Ind-Swift Labs.",
    "stock_name": "Ind-Swift Labs.",
    "full_name": "Ind-Swift Laboratories Ltd",
    "name_url": "stocks-analysis/ind-swift-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "316.95",
    "chg": -13.25,
    "chgp": "-4.01%",
    "dir": -1,
    "prev_price": "330.20",
    "mcapval": "2,831.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532305,
    "symbol": "INDSWFTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE915B01019",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "5.4 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-4263562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/IndSwiftLaborat_mojoScore_4263562.png",
        "date": "2026-11-16 10:11:45",
        "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-4251997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/IndSwiftLaborat_mojoScore_4251997.png",
        "date": "2026-11-05 10:12:12",
        "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Ind-Swift Laboratories Gains 12.08%: 3 Key Factors Driving the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/ind-swift-laboratories-gains-1208-3-key-factors-driving-the-rally-4246161",
        "imagepath": "",
        "date": "2026-10-31 17:07:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens strong at Rs.337.95 (+3.10%)</p>\n                    <p><strong>27 Oct:</strong> Sharp rally to Rs.368.25 (+8.97%) on heavy volume</p>\n                    <p><strong>28 Oct:</strong> Moderate gain to Rs.379.45 (+3.04%) despite Sensex dip</p>\n                    <p><strong>29 Oct:</strong> Surge to Rs.408.85 (+7.75%) with record volume</p>\n                    <p><strong>30 Oct:</strong> New 52-week and all-time high intraday at Rs.426; closes lower at Rs.367.40 (-10.14%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.327.80</..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits All-Time High of Rs 426 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-all-time-high-at-rs426-4244203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndSwiftLaborat_priceRelatedfactors_4244203.png",
        "date": "2026-10-30 09:32:03",
        "description": "Extending a remarkable five-day winning streak, Ind-Swift Laboratories Ltd surged to a fresh all-time high of Rs 426 on 30 Oct 2026, marking a significant milestone in its recent rally. This advance comes amid sustained outperformance against the broader sector and a backdrop of strong technical momentum."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Reports Outstanding Quarterly Financial Performance Amid Strong Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/ind-swift-laboratories-ltd-reports-outstanding-quarterly-financial-performance-amid-strong-market-returns-4243725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndSwiftLaborat_fintrenddot_4243725.png",
        "date": "2026-10-30 08:00:09",
        "description": "Ind-Swift Laboratories Ltd has delivered an outstanding quarterly performance for September 2026, marking a significant improvement in its financial trend and market standing. The pharmaceutical and biotechnology company reported record-high revenues, profits, and margins, reflecting robust operational execution and a favourable market environment. This performance has contributed to a notable upgrade in its Mojo Grade from Sell to Hold, signalling renewed investor confidence."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-sell-4237731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndSwiftLaborat_mojoScore_4237731.png",
        "date": "2026-10-25 10:10:40",
        "description": "Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Falls 0.55%: Downgrade and Mixed Technical Signals Shape Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/ind-swift-laboratories-ltd-falls-055-downgrade-and-mixed-technical-signals-shape-week-4228963",
        "imagepath": "",
        "date": "2026-10-17 17:06:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>12 Oct:</strong> Stock opens at Rs.361.00, marginally down 0.03%</p>\n                    <p><strong>13 Oct:</strong> MarketsMOJO downgrades Ind-Swift Laboratories Ltd to Sell</p>\n                    <p><strong>14 Oct:</strong> Technical momentum shifts to mildly bullish amid mixed indicator signals</p>\n                    <p><strong>16 Oct:</strong> Week closes at Rs.359.10, down 0.55% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.361.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/ind-swift-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4225006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndSwiftLaborat_mojoScore_4225006.png",
        "date": "2026-10-14 08:23:47",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 Oct 2026. This revision reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively temper the stock’s appeal despite its impressive recent returns."
      },
      {
        "title": "Ind-Swift Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/ind-swift-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4224768",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndSwiftLaborat_technicaldot_4224768.png",
        "date": "2026-10-14 08:02:21",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day change of 0.08%, the stock’s technical parameters reveal a transition from a bullish to a mildly bullish trend, prompting a reassessment of its near-term outlook."
      }
    ],
    "total": 89,
    "sid": "393806",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/ind-swift-laboratories-393806"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "10-Nov-2026",
      "details": "Please find enclosed transcript for earnings call held on November 04 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "04-Nov-2026",
      "details": "Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "04-Nov-2026",
      "details": "Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11",
          "dt": "2011-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

10-Nov-2026 | Source : BSE

Please find enclosed transcript for earnings call held on November 04 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

04-Nov-2026 | Source : BSE

Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026.

Announcement under Regulation 30 (LODR)-Investor Presentation

04-Nov-2026 | Source : BSE

Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Ind-Swift Laboratories Ltd has declared 10% dividend, ex-date: 20 Sep 11

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available